Asbestos exposure is the biggest contributor to the development of mesothelioma.[footnote num="1"] Most people with a diagnosis experienced asbestos exposure on the job, where they inhaled the small, damaging fibers without knowing the risks. Other potential mesothelioma causes or risk factors include genetics and family history and exposure to talcum powder contaminated with asbestos.
Life expectancy is an estimate of how long a patient will survive after a diagnosis, and it depends on the stage of the disease. The overall survival time for all stages is 15 months. It is longer for the early stages and shorter for the late-stage diagnoses.[footnote num="1"]
A mesothelioma lawyer is a legal professional you need on your side if you have been diagnosed with mesothelioma. Your illness probably resulted from negligent, workplace asbestos exposure, and someone should be held accountable.[footnote num="1"] The right attorney has the knowledge and experience to help you make the best choices as you take legal action.
Mesothelioma is an aggressive cancer with no cure and a poor prognosis.[footnote num="1"] Some patients live longer than others, but the median survival time for all types of mesothelioma is just 15 months.[footnote num="2"] Doctors provide a prognosis, the overall survival outlook, for each patient after diagnosis, which is important for informing treatment and also helping patients understand what to expect.
Innovative stem cell research is being conducted by mesothelioma specialists at the Pacific Heart, Lung and Blood Institute. There are hopes that the novel approach may be able to provide new hope for those suffering from this most-serious of asbestos-related diseases, as well as for other forms of cancer including lung cancer and cancers of
A new report published in the Journal of Occupational and Environmental Medicine indicated that mesothelioma is a risk no matter how high or low the level of asbestos exposure occurs. The information was culled from data gathered as part of the Netherlands Cohort Study, a study that has been conducted since 1986 that involves over
Those mesothelioma patients that have already undergone a chemotherapeutic course course of pemetrexed may gain benefits from undergoing a second course with a different medication known as vinorelbine. Though Pemetrexed and a platinum-based medication called cisplatin are the most traditional first-line course of chemotherapy treatment used in mesothelioma patients, physicians have found that the use
A study presented at the 15th World Conference on Lung Cancer has provided controversial information. It indicates that when the patients who are deemed healthiest among mesothelioma victims undergo surgery, it does not provide an appreciable improvement in the patient’s survival rates. The study was conducted in Italy and included data from almost 1,400 patients
The results of a new study were released by researchers from the Queen Mary’s Barts Cancer Institute in London, and they offer great promise for those hoping to slow down or stop the growth of mesothelioma tumors. The results, which revolved around the application of a new drug that is designed to deprive the tumor
A recent study conducted by scientists at Papworth Hospital in Cambridge, United Kingdom,indicated that an invasive keyhole surgery called video-assisted thoracoscopic surgery, or VATS, does nothing to extend mesothelioma patients’ survival rates but does make a considerable improvement in their quality of life. The study was presented at the 15th World Conference on Lung Cancer.